Cargando…
Living with liver disease in the era of COVID-19-the impact of the epidemic and the threat to high-risk populations
The cardinal symptoms of severe acute respiratory syndrome coronavirus 2 infection as the pandemic began in 2020 were cough, fever, and dyspnea, thus characterizing the virus as a predominantly pulmonary disease. While it is apparent that many patients presenting acutely to the hospital with coronav...
Autores principales: | Barve, Pranav, Choday, Prithi, Nguyen, Anphong, Ly, Tri, Samreen, Isha, Jhooty, Sukhwinder, Umeh, Chukwuemeka A, Chaudhuri, Sumanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850990/ https://www.ncbi.nlm.nih.gov/pubmed/36683630 http://dx.doi.org/10.12998/wjcc.v10.i36.13167 |
Ejemplares similares
-
Safety of ACEi and ARB in COVID‐19 management: A retrospective analysis
por: Kumar, Sabina, et al.
Publicado: (2022) -
Septic Portal Vein Thrombosis, Clinical Presentation, and Management
por: Anand, Simran, et al.
Publicado: (2021) -
Elevated Adrenocorticotropic Hormone, Hypercortisolism, and Marked Hypernatremia
por: Wassel, Elias, et al.
Publicado: (2021) -
Meta-analysis and systematic literature review of COVID-19 associated bradycardia as a predictor of mortality
por: Umeh, Chukwuemeka A., et al.
Publicado: (2022) -
A Multicenter Retrospective Analysis on the Etiology of Bradycardia in COVID-19 Patients
por: Umeh, Chukwuemeka, et al.
Publicado: (2022)